Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma; it features extreme molecular heterogeneity regardless of the classical cell-of-origin (COO) classification. Despite this, the standard therapeutic approach is still immunochemotherapy (rituximab plus cyclophosphamide, do...

Descripción completa

Detalles Bibliográficos
Autores principales: Coccaro, Nicoletta, Anelli, Luisa, Zagaria, Antonella, Perrone, Tommasina, Specchia, Giorgina, Albano, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017344/
https://www.ncbi.nlm.nih.gov/pubmed/31940809
http://dx.doi.org/10.3390/cancers12010185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017344/
https://www.ncbi.nlm.nih.gov/pubmed/31940809
http://dx.doi.org/10.3390/cancers12010185

Ejemplares similares